Sign in
4

Changes in Ownership

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-23-004883

Chief Financial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Szot Matthew K · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-24 Grant or award : show line 1 in the form +50,000 500,000 D
Loading xslF345X03/ownership.xml…